COVID-19 Updates: January 3, 2022
Treatment Updates Emergency Use Authorization granted to 2 oral antivirals for COVID-19 treatment The FDA granted Emergency Use Authorization (EUA) […]
Treatment Updates Emergency Use Authorization granted to 2 oral antivirals for COVID-19 treatment The FDA granted Emergency Use Authorization (EUA) […]
Variant and Vaccine Updates Why are there different variants of COVID-19? Like any virus, COVID-19 can and will change over
On this May 21, 2020 webinar, Maxor’s Clinical and Pharmacy Compliance experts discuss global data trends and the new normal
On this April 30, 2020 webinar, Maxor’s Clinical team examines the data uncovered during month of April including testing and
We are pleased to bring you another update on the COVID-19 pandemic and Maxor’s response. Despite the abrupt disruption to normal
On this April 2, 2020 webinar, Maxor’s Clinical team reviews the latest COVID-19 data and related drug pipeline trends and
As the COVID-19 crisis continues to unfold, we know it is important to keep you updated on our response, perspective,
While these are unprecedented times in many ways – in adversity we find our strength. Over the last few weeks
This is the first communication of a regular publication that Maxor will release related to our Corona virus (COVID-19) perspective
This memo details Maxor’s perspective on the current COVID-19 situation and contingency planning across Maxor’s various business lines, including PBM,